FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

SANGEETA RAY

Research Profile

Chemicals & Drugs

Concepts & Ideas

Living Beings

Phenomena

Magnetic Resonance Spectroscopy

Procedures

Isotope Labeling

Co-author Network

Publications

TOP 3
Ying Chen; RONNIE MEASE; SANGEETA RAY; Youngjoo Byun; Mrudula Pullambhatla; Camilo Rojas; Barbara Slusher; M Stathis; Martin G Pomper
Synthesis and biological evaluation of low molecular weight fluorescent imaging agents for the prostate-specific membrane antigen.
Zhihang Chen; Kristine Glunde; Cong Li; Sridhar Nimmagadda ; Marie-France Penet; Martin G Pomper; Paul T Winnard; Dmitri Artemov; SANGEETA RAY; Zaver M Bhujwalla
PSMA-targeted theranostic nanoplex for prostate cancer therapy.
SANGEETA RAY; Ala Lisok; RONNIE MEASE; Mrudula Pullambhatla; Hassan Shallal; Martin G Pomper
A modular strategy to prepare multivalent inhibitors of prostate-specific membrane antigen (PSMA).

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of SANGEETA RAY (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Ying Chen; RONNIE MEASE; SANGEETA RAY; Youngjoo Byun; Mrudula Pullambhatla; Camilo Rojas; Barbara Slusher; M Stathis; Martin G Pomper
Synthesis and biological evaluation of low molecular weight fluorescent imaging agents for the prostate-specific membrane antigen.
Bioconjugate chemistry 2012;23(12):2377-85.
2012: Zhihang Chen; Kristine Glunde; Cong Li; Sridhar Nimmagadda ; Marie-France Penet; Martin G Pomper; Paul T Winnard; Dmitri Artemov; SANGEETA RAY; Zaver M Bhujwalla
PSMA-targeted theranostic nanoplex for prostate cancer therapy.
ACS nano 2012;6(9):7752-62.
2011: SANGEETA RAY; Ala Lisok; RONNIE MEASE; Mrudula Pullambhatla; Hassan Shallal; Martin G Pomper
A modular strategy to prepare multivalent inhibitors of prostate-specific membrane antigen (PSMA).
Oncotarget 2011;2(12):1244-53.
2011: SANGEETA RAY; Youngjoo Byun; Catherine A Foss; James J Fox; Gilbert Green; Shawn E Lupold; RONNIE MEASE; Sridhar Nimmagadda ; Mrudula Pullambhatla; Martin G Pomper
Sequential SPECT and optical imaging of experimental models of prostate cancer with a dual modality inhibitor of the prostate-specific membrane antigen.
Angewandte Chemie (International ed. in English) 2011;50(39):9167-70.
2010: SANGEETA RAY; Mrudula Pullambhatla; Youngjoo Byun; Sridhar Nimmagadda ; Gilbert Green; James J Fox; Andrew G Horti; RONNIE MEASE; Martin G Pomper
68Ga-labeled inhibitors of prostate-specific membrane antigen (PSMA) for imaging prostate cancer.
Journal of medicinal chemistry 2010;53(14):5333-41.
2009: Ying Chen; Surajit Dhara; SANGEETA RAY; Youngjoo Byun; Mrudula Pullambhatla; RONNIE MEASE; Martin G Pomper
A low molecular weight PSMA-based fluorescent imaging agent for cancer.
Biochemical and biophysical research communications 2009;390(3):624-9.
2009: Aaron M LeBeau; SANGEETA RAY; Martin G Pomper; RONNIE MEASE; Samuel R Denmeade
Optimization of peptide-based inhibitors of prostate-specific antigen (PSA) as targeted imaging agents for prostate cancer.
Bioorganic & medicinal chemistry 2009;17(14):4888-93.
2008: Cyril Barinka; Youngjoo Byun; Crystal L Dusich; SANGEETA RAY; Ying Chen; Mark Castanares; Alan P Kozikowski; RONNIE MEASE; Martin G Pomper; Jacek Lubkowski
Interactions between human glutamate carboxypeptidase II and urea-based inhibitors: structural characterization.
Journal of medicinal chemistry 2008;51(24):7737-43.
2008: SANGEETA RAY; Catherine A Foss; Mark Castanares; RONNIE MEASE; Youngjoo Byun; James J Fox; John Hilton; Shawn E Lupold; Alan P Kozikowski; Martin G Pomper
Synthesis and evaluation of technetium-99m- and rhenium-labeled inhibitors of the prostate-specific membrane antigen (PSMA).
Journal of medicinal chemistry 2008;51(15):4504-17.
2008: Sachin S Chandran; SANGEETA RAY; RONNIE MEASE; Martin G Pomper; Samuel R Denmeade
Characterization of a targeted nanoparticle functionalized with a urea-based inhibitor of prostate-specific membrane antigen (PSMA).
Cancer biology & therapy 2008;7(6):974-82.
2005: SANGEETA RAY; Paul Schaffer; John Babich; John F Valliant; Jon Zubieta
Design and synthesis of site directed maleimide bifunctional chelators for technetium and rhenium.
Dalton transactions (Cambridge, England : 2003) 2005;(24):3886-97.
2005: Karin A Stephenson; SANGEETA RAY; Oyebola O Sogbein; Murali K Levadala; Nicole McFarlane; Douglas R Boreham; Kevin P Maresca; John Babich; Jon Zubieta; John F Valliant
A new strategy for the preparation of peptide-targeted technetium and rhenium radiopharmaceuticals. The automated solid-phase synthesis, characterization, labeling, and screening of a peptide-ligand library targeted at the formyl peptide receptor.
Bioconjugate chemistry 2005;16(5):1189-95.
2005: SANGEETA RAY; Kevin P Maresca; Karin A Stephenson; John F Valliant; John Babich; Wendy A Graham; Marlene Barzana; Qing Dong; Alan J Fischman; Jon Zubieta
N,N-bis(2-mercaptoethyl)methylamine: a new coligand for Tc-99m labeling of hydrazinonicotinamide peptides.
Bioconjugate chemistry 2005;16(4):885-902.
2005: SANGEETA RAY; Jon Zubieta
A new tricarbonylrhenium(I) compound incorporating the tridentate ligand N,N-bispicolyl-2-ethanolamine.
Acta crystallographica. Section C, Crystal structure communications 2005;61(Pt 6):m275-7.
2005: SANGEETA RAY; John Babich; Jon Zubieta
Site directed maleimide bifunctional chelators for the M(CO)3+ core (M =(99m)Tc, Re).
Chemical communications (Cambridge, England) 2005;(13):1784-6.
2005: SANGEETA RAY; Kevin P Maresca; Lynn Francesconi; John F Valliant; John Babich; Jon Zubieta
New directions in the coordination chemistry of 99mTc: a reflection on technetium core structures and a strategy for new chelate design.
Nuclear medicine and biology 2005;32(1):1-20.
2004: Karin A Stephenson; SANGEETA RAY; Travis R Besanger; Oyebola O Sogbein; Murali K Levadala; Nicole McFarlane; Jennifer A Lemon; Douglas R Boreham; Kevin P Maresca; John D Brennan; John Babich; Jon Zubieta; John F Valliant
Bridging the gap between in vitro and in vivo imaging: isostructural Re and 99mTc complexes for correlating fluorescence and radioimaging studies.
Journal of the American Chemical Society 2004;126(28):8598-9.
2004: SANGEETA RAY; Jon Zubieta
A metal-mediated dimerization of the ligand bis(N,N-diethylamino)carbeniumdithiocarboxylate.
Acta crystallographica. Section C, Crystal structure communications 2004;60(Pt 5):m208-9.
2004: Karin A Stephenson; Jon Zubieta; SANGEETA RAY; Murali K Levadala; Linda Taggart; Lorna Ryan; Nicole McFarlane; Douglas R Boreham; Kevin P Maresca; John Babich; John F Valliant
A new strategy for the preparation of peptide-targeted radiopharmaceuticals based on an fmoc-lysine-derived single amino acid chelate (SAAC). automated solid-phase synthesis, NMR characterization, and in vitro screening of fMLF(SAAC)G and fMLF[(SAAC-Re(CO)3)+]G.
Bioconjugate chemistry 2004;15(1):128-36.
2002: SANGEETA RAY; Murali K Levadala; Neva Lazarova; Lihui Wei; John F Valliant; Karin A Stephenson; John Babich; Kevin P Maresca; Jon Zubieta
Bifunctional single amino acid chelates for labeling of biomolecules with the [Tc(CO)(3)](+) and [Re(CO)(3)](+) cores. Crystal and molecular structures of [ReBr(CO)(3)(H(2)NCH(2)C(5)H(4)N)], [Re(CO)(3)[(C(5)H(4)NCH(2))(2)NH]]Br, [Re(CO)(3)[(C(5)H(4)NCH(2))(2)NCH(2)CO(2)H]]Br, [Re(CO)(3)[X(Y)NCH(2)CO(2)CH(2)CH(3)]]Br (X = Y = 2-pyridylmethyl; X = 2-pyridylmethyl, Y = 2-(1-methylimidazolyl)methyl; X = Y = 2-(1-methylimidazolyl)methyl), [ReBr(CO)(3)[(C(5)H(4)NCH(2))NH(CH(2)C(4)H(3)S)]], and [Re(CO)(3)[(C(5)H(4)NCH(2))N(CH(2)C(4)H(3)S)(CH(2)CO(2))]].
Inorganic chemistry 2002;41(24):6417-25.
2002: SANGEETA RAY; Lihui Wei; Murali K Levadala; Neva Lazarova; Vladimir Golub; Charles J O'Connor; Karin A Stephenson; John F Valliant; John Babich; Jon Zubieta
[Re(III)Cl(3)] core complexes with bifunctional single amino acid chelates.
Inorganic chemistry 2002;41(22):5795-802.